All Topics → Forum: Survey, Interview and Participant Requests: Need your Help! → Topic: HR+/HER2-, Mets/Non-Mets Patients & Caregivers Survey
Research proposals and/or requests posted here by members have been reviewed and approved by the Moderator Team, but not associated with Breastcancer.org.
Posted on: Oct 3, 2017 03:28PM
Lieberman Research Worldwide (www.LRWonline.com) is conducting a market research study. The findings of this study will help our client to develop communications regarding a specific treatment for HR+/HER2- metastatic breast cancer patients and their caregivers. Your opinions matter.
The survey is intended for HR+/HER2- breast cancer patients and caregivers. If you qualify and complete this research, metastatic HR+/HER2- BC patients will receive a $100 in appreciation of your time and participation. Other HR+/HER2- BC patients or caregivers will receive $50 honorarium in appreciation of your time and participation. Alternatively, you can choose to donate this honorarium to the American Red Cross Hurricane Harvey Relief or the cancer charity of your choice.
Please be assured that all opinions in the survey remain anonymous and confidential. You will never be personally identified in the research; your responses will only be considered in aggregate. It's also important to note that this research is in no way sales related, and no one will try to sell you anything at any time.
We are excited for you to participate! If you would like to help us with this research, please click on the link below. This link will collect some information first in order to help us determine if you qualify. The survey will take 15 minutes.
Please note: While this survey is compatible on a desktop or laptop computer, smartphone or tablet, your experience will be best if taking the survey on a desktop or laptop computer.
We look forward to hearing your opinions and appreciate your time and participation.